However, ATR is frequently overexpressed in breast cancer, and its elevated expression levels are associated with advanced tumor stage and lymphovascular invasion (Abdel-Fatah et al., 2015), underscoring its potential as a therapeutic target. This evidence concerns the gene ATR and breast carcinoma.